Exagen Inc. (XGN) shareholders
Close on Nov 17, 2026Market cap $91.09MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Chernett Jorey | 2,413,901 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| James L.L. Tullis Joint filing with Tullis-Dickerson Capital Focus III, L.P. (6.50%), Tullis-Dickerson Partners III, L.L.C. (6.50%) | 1,867,116 | 10.70% | 13G (passive) amendment | Dec 31, 2023 |
| Roderick Wong Joint filing with RTW Investments, LP (7.70%) | 1,696,866 | 7.70% | 13G (passive) amendment | Jun 30, 2025 |
| NMSIC Co-Investment Fund, L.P. Joint filing with Sun Mountain Capital Partners, L.L.C. (6.04%) | 1,368,958 | 6.04% | 13G (passive) amendment | Dec 31, 2025 |
| Parian Ultreia LP | 1,292,000 | 5.30% | 13G (passive) | May 22, 2026 |
| Cowen Financial Products LLC | 891,366 | 5.00% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Wexford Capital LP | 792,855 | 3.27% | $3.69M | – | 0.47% |
| Nano Cap New Millennium Growth Fund L P | 675,000 | 2.79% | $3.14M | +90,000 | 2.41% |
| First Eagle Investment Management, LLC | 613,930 | 2.53% | $2.85M | +488,688 | 0.00% |
| Vanguard Capital Management LLC | 612,832 | 2.53% | $2.85M | −65,820 | 0.00% |
| FourWorld Capital Management LLC | 596,528 | 2.46% | $2.77M | +156,578 | 2.52% |
| Silvercrest Asset Management Group LLC | 514,761 | 2.12% | $2.39M | −23,109 | 0.02% |
| Kennedy Capital Management LLC | 485,048 | 2.00% | $2.26M | −8,612 | 0.04% |
| Mink Brook Asset Management LLC | 475,944 | 1.96% | $2.21M | +106,917 | 0.98% |
| Jane Street Group, LLC | 322,502 | 1.33% | $1.50M | +85,767 | 0.00% |
| Acadian Asset Management LLC | 310,084 | 1.28% | $1.44M | −379,030 | 0.00% |
| Marshall Wace, Llp | 306,703 | 1.27% | $1.43M | +279,414 | 0.00% |
| Flputnam Investment Management Co | 288,810 | 1.19% | $1.34M | New | 0.02% |
| Gsa Capital Partners Llp | 214,721 | 0.89% | $998.00K | −38,284 | 0.06% |
| Rtw Investments, LP | 195,000 | 0.80% | $906.75K | −200,231 | 0.01% |
| Geode Capital Management, LLC | 185,654 | 0.77% | $863.87K | +6,797 | 0.00% |
| Man Group plc | 167,292 | 0.69% | $777.91K | +37,582 | 0.00% |
| BlackRock, Inc. | 142,625 | 0.59% | $663.21K | +16,739 | 0.00% |
| Perceptive Advisors LLC | 114,893 | 0.47% | $534.25K | – | 0.01% |
| XTX Topco Ltd | 111,948 | 0.46% | $520.56K | −130,337 | 0.01% |
| Sei Investments Co | 109,005 | 0.45% | $506.87K | −135,235 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 57 | 8M | 34.1% | 8 / 15 | 24 / 11 | 2M | 3M |
| Q1 2026 | 61 | 10M | 39.9% | 8 / 25 | 22 / 26 | 3M | 4M |
| Q4 2025 | 80 | 11M | 44.6% | 26 / 33 | 16 / 8 | 4M | 2M |
| Q3 2025 | 62 | 9M | 37.4% | 19 / 24 | 13 / 10 | 3M | 3M |
| Q2 2025 | 53 | 9M | 38.0% | 22 / 17 | 5 / 7 | 4M | 1M |
| Q1 2025 | 38 | 6M | 25.7% | 4 / 10 | 10 / 7 | 0M | 0M |
| Q4 2024 | 41 | 6M | 25.2% | 10 / 8 | 14 / 2 | 1M | 2M |
| Q3 2024 | 33 | 6M | 26.3% | 3 / 8 | 9 / 2 | 0M | 0M |
| Q2 2024 | 33 | 6M | 26.2% | 2 / 11 | 12 / 0 | 0M | 1M |
| Q1 2024 | 31 | 7M | 29.6% | 1 / 8 | 12 / 0 | 1M | 1M |
| Q4 2023 | 30 | 7M | 29.6% | 3 / 7 | 10 / 2 | 1M | 1M |
| Q3 2023 | 29 | 7M | 28.3% | 3 / 6 | 8 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
26 funds held XGN in Q2 2026, 66% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of XGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| First Eagle Small Cap Opportunity Fund | 435,574 | 1.80% | $1.97M | 0.07% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 414,852 | 1.71% | $1.93M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 179,415 | 0.74% | $834.28K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 82,372 | 0.34% | $410.21K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 55,958 | 0.23% | $260.20K | 0.02% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 25,808 | 0.11% | $128.52K | 0.00% | May 31, 2026 |
| North Square Kennedy Microcap Fund | 25,452 | 0.11% | $126.75K | 0.38% | May 31, 2026 |
| Dimensional U.S. Small Cap ETF | 25,070 | 0.10% | $113.57K | 0.00% | Jul 31, 2026 |
| Ultra-Small Company Market Fund | 24,802 | 0.10% | $115.33K | 0.08% | Jun 30, 2026 |
| Fidelity Series Total Market Index Fund | 22,903 | 0.09% | $114.06K | 0.00% | May 31, 2026 |
| Perkins Discovery Fund | 15,000 | 0.06% | $45.00K | 0.78% | Mar 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 11,992 | 0.05% | $59.72K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 10,707 | 0.04% | $49.79K | 0.00% | Jun 30, 2026 |
| U.S. Micro Cap Portfolio | 8,014 | 0.03% | $36.30K | 0.00% | Jul 31, 2026 |
| Vanguard Balanced Index Fund | 7,858 | 0.03% | $36.54K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John Aballi | President and CEO, Director | 845,941 | 3.49% | Oct 19, 2026 |
| Jeffrey G. Black | Chief Financial Officer | 324,910 | 1.34% | Sep 2, 2026 |
| Tina Susan Nova | Director | – | – | Nov 2, 2026 |
| Bruce C. Robertson | Director | – | – | Aug 24, 2026 |
| Paul Kim | Director | – | – | Aug 19, 2026 |
| Chas McKhann | Director | 7,500 | 0.03% | Jun 22, 2026 |
| Frank Stokes | Director | – | – | Jun 22, 2026 |
| Scott D. Kahn | Director | – | – | Jun 22, 2026 |
| Ana Hooker | Director | – | – | Jun 12, 2025 |
| Jorey Chernett | 10% owner | 2,529,436 | 10.44% | Nov 13, 2026 |
| NMSIC Co-Investment Fund, L.P. | 10% owner | 1,758,958 | 7.26% | Mar 27, 2025 |
| Mountain Capital Partners LLC Sun | 10% owner | 2,108,958 | 8.71% | Mar 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jorey Chernett 10% owner | Nov 13, 2026 | Sale | −58,068 | $4.08 | $236.92K | 2,529,436 |
| Jorey Chernett 10% owner | Nov 12, 2026 | Sale | −109,436 | $4.65 | $508.88K | 2,587,504 |
| Jorey Chernett 10% owner | Nov 11, 2026 | Buy | +71,315 | $5.23 | $372.98K | 2,696,940 |
| Jorey Chernett 10% owner | Nov 10, 2026 | Buy | +7,085 | $5.26 | $37.27K | 2,625,625 |
| Jorey Chernett 10% owner | Nov 9, 2026 | Buy | +8,500 | $6.35 | $53.98K | 2,618,540 |
| Jorey Chernett 10% owner | Nov 6, 2026 | Sale | −11,265 | $6.14 | $69.17K | 2,610,040 |
| Jorey Chernett 10% owner | Oct 19, 2026 | Buy | +14,000 | $7.46 | $104.44K | 2,618,540 |
| John Aballi President and CEO, Director | Oct 16, 2026 | Sale | −34,294 | $7.87 | $269.79K | 805,540 |
| Jeffrey G. Black Chief Financial Officer | Sep 1, 2026 | Award | +1,571 | $3.02 | $4.74K | 324,910 |
| Jeffrey G. Black Chief Financial Officer | Sep 1, 2026 | Sale | −20,614 | $7.22 | $148.83K | 323,339 |
| John Aballi President and CEO, Director | Mar 12, 2026 | Award | +150,000 | – | – | 839,834 |
| Jeffrey G. Black Chief Financial Officer | Mar 12, 2026 | Award | +75,000 | $3.16 | $237.00K | 342,442 |
| John Aballi President and CEO, Director | Mar 3, 2026 | Sale | −15,698 | $3.62 | $56.83K | 687,299 |
| John Aballi President and CEO, Director | Mar 3, 2026 | Award | +2,535 | $3.08 | $7.81K | 689,834 |
| Jeffrey G. Black Chief Financial Officer | Feb 27, 2026 | Award | +1,511 | $3.08 | $4.65K | 343,953 |
| Jeffrey G. Black Chief Financial Officer | Feb 24, 2026 | Sale | −1,584 | $3.61 | $5.72K | 267,442 |
| John Aballi President and CEO, Director | Feb 24, 2026 | Sale | −11,430 | $3.61 | $41.26K | 702,997 |
| John Aballi President and CEO, Director | Oct 16, 2025 | Sale | −31,787 | $11.82 | $375.72K | 714,427 |
| Jeffrey G. Black Chief Financial Officer | Sep 2, 2025 | Sale | −20,466 | $9.79 | $200.36K | 269,026 |
| NMSIC Co-Investment Fund, L.P. 10% owner | Mar 25, 2025 | Sale | −350,000 | $3.30 | $1.16M | 1,758,958 |
| John Aballi President and CEO, Director | Feb 28, 2025 | Award | +8,621 | $2.47 | $21.29K | 746,214 |
| John Aballi President and CEO, Director | Feb 21, 2025 | Award | +112,500 | – | – | 737,593 |
| Jeffrey G. Black Chief Financial Officer | Feb 21, 2025 | Award | +15,000 | – | – | 289,492 |
| Mountain Capital Partners LLC Sun 10% owner | Nov 20, 2024 | Sale | −200,000 | $3.30 | $660.00K | 2,108,958 |
| Jeffrey G. Black Chief Financial Officer | Nov 15, 2024 | Buy | +22,298 | $2.98 | $66.45K | 274,492 |
| John Aballi President and CEO, Director | Nov 14, 2024 | Buy | +24,305 | $2.81 | $68.30K | 689,799 |
| Jeffrey G. Black Chief Financial Officer | Sep 1, 2024 | Award | +225,000 | – | – | 252,194 |
| John Aballi President and CEO, Director | May 16, 2024 | Buy | +40,401 | $1.92 | $77.57K | 40,401 |
| Kamal Adawi CFO and Corporate Secretary | Mar 4, 2024 | Sale | −9,297 | $1.91 | $17.76K | 247,236 |
| Kamal Adawi CFO and Corporate Secretary | Mar 4, 2024 | Sale | −3,487 | $1.91 | $6.66K | 243,749 |
| John Aballi President and CEO, Director | Feb 29, 2024 | Award | +9,804 | $1.91 | $18.73K | 600,788 |
| John Aballi President and CEO, Director | Feb 20, 2024 | Award | +175,000 | – | – | 590,984 |
| Kamal Adawi CFO and Corporate Secretary | Feb 20, 2024 | Award | +75,000 | – | – | 256,533 |
| Kamal Adawi CFO and Corporate Secretary | Feb 6, 2024 | Sale | −6,738 | $1.95 | $13.14K | 181,533 |
| John Aballi President and CEO, Director | Oct 17, 2023 | Sale | −33,819 | $1.75 | $59.18K | 415,984 |
| John Aballi President and CEO, Director | Aug 31, 2023 | Award | +9,803 | $2.14 | $20.98K | 449,803 |
| Tullis Growth Fund Ii, L.P. 10% owner | Jun 15, 2023 | Buy | +167 | $3.11 | $519 | 1,515,839 |
| Mark Hazeltine Chief Business Officer | Mar 2, 2023 | Sale | −3,667 | – | – | 190,205 |
| Kamal Adawi CFO and Corporate Secretary | Mar 2, 2023 | Sale | −3,667 | $2.30 | $8.43K | 188,271 |
| Kamal Adawi CFO and Corporate Secretary | Feb 27, 2023 | Award | +100,000 | – | – | 191,938 |
| Mark Hazeltine Chief Business Officer | Feb 27, 2023 | Award | +100,000 | – | – | 193,872 |
| Mark Hazeltine Chief Business Officer | Feb 8, 2023 | Sale | −5,821 | $2.69 | $15.66K | 93,872 |
| Kamal Adawi CFO and Corporate Secretary | Feb 8, 2023 | Sale | −5,821 | $2.69 | $15.66K | 91,938 |
| John Aballi President and CEO, Director | Dec 8, 2022 | Buy | +90,000 | $2.68 | $241.20K | 440,000 |
| John Aballi President and CEO, Director | Oct 16, 2022 | Award | +350,000 | – | – | 350,000 |
| Mark Hazeltine Chief Operating Officer | Mar 1, 2022 | Tax withholding | −3,241 | $7.12 | $23.08K | 99,693 |
| Kamal Adawi CFO and Corporate Secretary | Mar 1, 2022 | Tax withholding | −3,241 | $7.12 | $23.08K | 97,759 |
| Fortunato R. Rocca President and CEO, Director | Mar 1, 2022 | Tax withholding | −4,322 | $7.12 | $30.77K | 120,678 |
| Debra Zack Chief Medical Officer | Mar 1, 2022 | Tax withholding | −3,241 | $7.12 | $23.08K | 84,259 |
| Mark Hazeltine Chief Operating Officer | Feb 4, 2022 | Award | +63,500 | – | – | 102,934 |
| Fortunato R. Rocca President and CEO, Director | Feb 4, 2022 | Award | +75,000 | – | – | 125,000 |
| Debra Zack Chief Medical Officer | Feb 4, 2022 | Award | +50,000 | – | – | 87,500 |
| Kamal Adawi CFO and Corporate Secretary | Feb 4, 2022 | Award | +63,500 | – | – | 101,000 |
| Wendy S. Johnson Director | Sep 3, 2021 | Buy | +1,000 | $14.02 | $14.02K | 1,000 |
| James L. L. Tullis Director | Aug 5, 2021 | Sale(10b5-1 plan) | −6,800 | $10.72 | $72.90K | 1,515,672 |
| James L. L. Tullis Director | Aug 4, 2021 | Sale(10b5-1 plan) | −2,100 | $11.39 | $23.92K | 1,522,472 |
| James L. L. Tullis Director | Aug 3, 2021 | Sale(10b5-1 plan) | −4,300 | $11.77 | $50.61K | 1,524,572 |
| James L. L. Tullis Director | Aug 2, 2021 | Sale(10b5-1 plan) | −1,800 | $11.92 | $21.46K | 1,528,872 |
| James L. L. Tullis Director | Jun 29, 2021 | Sale(10b5-1 plan) | −5,379 | $14.67 | $78.91K | 1,530,672 |
| James L. L. Tullis Director | Jun 28, 2021 | Sale(10b5-1 plan) | −10,858 | $14.98 | $162.65K | 1,536,051 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Exagen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,000 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kamal Adawi Officer | Oct 8, 2024 | 84,162 | $247.44K | Oct 8, 2024 | EXERCISED SHARES |
| Kamal Adawi Officer | Aug 9, 2024 | 52,624 | $145.24K | Aug 9, 2024 | RESTRICTED STOCK |
See a number that looks wrong?